Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Teva Pharmaceutical Industries Limited

Teva to Host Conference Call to Discuss First Quarter 2021 Financial Results at 8 a.m. ET on April 28, 2021
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its financial results for the first quarter on Wednesday, April 28, 2021 at 7:00 a.m. ET.... 
Tickers TEVA
From Business Wire News Releases
Teva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressure inside the eye, in the United States
Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced its launch of the first available generic version of AZOPT® (brinzolamide... 
Tickers TEVA
From Business Wire News Releases
Teva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance Conference
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Executive Vice President & CFO Eli Kalif will present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance... 
Tickers TEVA
From Business Wire News Releases
New Study Published in Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine Treatments
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) highlights results from the in vitro study “Migraine Therapeutics Differentially Modulate the CGRP Pathway,” which were published online by... 
Tickers TEVA
From Business Wire News Releases
Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring in the United States
Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced the availability of a generic version of NuvaRing®1 (etonogestrel and... 
Tickers TEVA
From Business Wire News Releases
Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2020 financial results, as well as on its financial... 
Tickers TEVA
From Business Wire News Releases
Teva to Present at the 39th Annual J.P. Morgan Healthcare Conference
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that President & CEO Kåre Schultz will present at the 39th Annual J.P. Morgan Healthcare Conference in San Francisco,... 
Tickers TEVA
From Business Wire News Releases
Teva Reports Third Quarter 2020 Financial Results
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended September 30, 2020. 
Tickers TEVA
From Business Wire News Releases
Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio
Teva Respiratory, LLC, an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the company is collaborating with Amazon Web Services, Inc. (AWS) and Onica, a... 
Tickers TEVA
From Business Wire News Releases
Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) and ATRIPLA® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil f
Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the availability of the first Food and Drug Administration (FDA)-approved... 
Tickers TEVA
From Business Wire News Releases
Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5, 2020
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter financial results, Thursday November 5, 2020 at 7:00 a.m. ET. Following... 
Tickers TEVA
From Business Wire News Releases
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva Launches Two Digital Maintenance Inhalers for the Treatment of Asthma in the U.S. 
Tickers TEVA
From Business Wire News Releases
First Long-Term Data on the use of AJOVY® (fremanezumab-vfrm) Injection in Patients with Migraine Published in Neurology
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that results from the 52-week, multicenter, randomized, double-blind, parallel group study evaluating monthly or quarterly... 
Tickers TEVA
From Business Wire News Releases
Teva to Present New Data at The MDS Virtual Congress 2020 and Psych Congress 2020 Virtual Experience Evaluating Long-Term Treatment with AUSTEDO® (deutetrabenazine) Tablets
Teva Neuroscience, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will present new study data on AUSTEDO at the International Parkinson and Movement Disorder Society... 
Tickers TEVA
From Business Wire News Releases
Teva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at the MDS Virtual Congress 2020 and Psych Congress 2020 Virtual Experience
Teva Neuroscience, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that new study data on AUSTEDO® (deutetrabenazine) will be presented at the... 
Tickers TEVA
From Business Wire News Releases
Statement in Response to News of the Indictment of Teva USA
Today Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) is responding to news reports detailing that a federal grand jury in Philadelphia, Pennsylvania has returned a criminal indictment... 
Tickers TEVA
From Business Wire News Releases
Teva Announces New Strategic Focus in the Japanese Market
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), who holds (through its Japanese affiliates) with Takeda a joint business venture (the "BV") in the Japanese market, announced today a new... 
Tickers TEVA
From Business Wire News Releases
Teva Announces New Drug Application Filing in Japan for AJOVY® (fremanezumab) Injection
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced Otsuka Pharmaceutical Co., Ltd. has submitted an application to the Pharmaceuticals and Medical Devices Agency of Japan to... 
Tickers TEVA
From Business Wire News Releases
Teva Announces Availability of ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder for Patients with Asthma and COPD
Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder, the... 
Tickers TEVA
From Business Wire News Releases
Teva to Host Conference Call to Discuss Second Quarter 2020 Financial Results at 8 a.m. ET on August 5, 2020
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter financial results on Wednesday August 5, 2020 at 7:00 a.m. ET.... 
Tickers TEVA
From Business Wire News Releases
Teva Announces Launch of $1,500,000,000 Offering of Senior Notes
Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) (“Teva”) announced today the following private offering of senior notes: 
Tickers TEVA
From Business Wire News Releases
Teva Announces Upsizing and Successful Pricing of $4.5 Billion of Senior Notes
Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully priced the offering of $4.5 billion of its previously announced senior notes (the “Notes”).... 
Tickers TEVA
From Business Wire News Releases
Teva Announces Launch of Offering of Senior Notes
Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) (“Teva”) announced today that its special purpose finance subsidiary, (i) Teva Pharmaceutical Finance Netherlands II B.V. (“Teva Finance... 
Tickers TEVA
From Business Wire News Releases
Teva Announces Pricing of €2 Billion of Senior Notes
Tickers TEVA
From Business Wire News Releases
Teva Announces Pricing of $2.0 Billion of Senior Notes
Tickers TEVA
From Business Wire News Releases
Teva Receives A- Rating from Fitch Ratings with a Stable Outlook
Tickers TEVA
From Business Wire News Releases
Teva Announces Pricing of $750,000,000 of Senior Notes
Tickers TEVA
From Business Wire News Releases
Teva Announces Completion of $2.5 Billion of Senior Notes Offering
Tickers TEVA
From Business Wire News Releases
Teva Announces Pricing of $2.5 Billion of Senior Notes
Tickers TEVA
From Business Wire News Releases
Teva Reports Third Quarter 2009 Results
Record Sales, Non-GAAP Net Income and Non-GAAP EPS 
Tickers TEVA
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account